JPRN-C000000316已完成未知
An open, randomized, parallel group, multi-center study on the effect of a resume of Renal Anemia Treatment by Erythropoietin supplemented with Iron and vitamin C on the Prognosis in Hemodialysis Patients - ACTIVE
Department of Kidney and Dialysis, Hyogo College of Medicine0 个研究点目标入组 450 人开始时间: 2006年4月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with malignancy, infection and severe liver and lung diseases, 2)Patients receiving steroids and immunosuppressants
研究者
相似试验
进行中（未招募）
不适用
A randomized, open, parallel-group, multi-centre, phase IV study toevaluate the efficacy of three different patient management strategies withand without esomeprazole 20 mg during a 3 months maintenance phasefollowing an initial 4-weeks acute treatment phase in subjects withsymptoms thought to be GERD related - SYMPATHYSymptoms thought to be gastroesophageal reflux disease (GERD)-relatedEUCTR2006-001316-76-DEAstraZeneca GmbH7,600
进行中（未招募）
不适用
An open, randomised, parallel group, multicentre study to compare the efficacy and safety of FlutiFormTM pMDI compared with Fluticasone pMDI plus Formoterol DPI in adolescent and adult subjects with mild to moderate-severe persistent, reversible asthma. - FLAIR studieAsthma bronchial.MedDRA version: 9.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2007-001634-13-BEMundipharma Research Ltd.200
进行中（未招募）
不适用
An open, randomised, parallel group, multicentre study to compare the efficacyand safety of FlutiForm pMDI vs Seretide pMDI in paediatric subjects withmild to moderate persistent, reversible asthma.Asthma bronchialMedDRA version: 8.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2006-005928-16-CZMundipharma Research Ltd.200
进行中（未招募）
不适用
An open, randomised, parallel group, multicentre study to compare the efficacyand safety of FlutiForm pMDI vs Seretide pMDI in paediatric subjects withmild to moderate persistent, reversible asthma.Asthma bronchialMedDRA version: 8.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2006-005928-16-HUMundipharma Research Ltd.200
进行中（未招募）
1 期
An open, randomised, parallel group, multicentre study to compare the efficacyand safety of FlutiForm pMDI vs Seretide pMDI in paediatric subjects withmild to moderate persistent, reversible asthma.EUCTR2006-005928-16-FRMundipharma Research Ltd.